Abstract Details
|
Neil Datta, MD
(Cambridge Health Alliance)
PRESENTER |
Dr. Datta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LEK consulting. Dr. Datta has received personal compensation in the range of $0-$499 for serving as a Consultant for Spherix Global. |
| Bhaskar Roy, MD, FAAN (Yale University) | Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has stock in Cabaletta bio. . The institution of Dr. Roy has received research support from Martin Shubik Fund for IBM at Yale University. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. |
| Ekaterina Bakradze, MD (University of Alabama At Birmingham) | Dr. Bakradze has nothing to disclose. |
| David M. Waitzman, MD | No disclosure on file |